Sanjing Industrial Park * * Scenic Area 19 shows the production and operation of Sanjing Pharmaceutical from different aspects. The first-class production equipment, advanced product production technology, strict quality assurance system and the historical development of Sanjing Pharmaceutical are highlighted. In order to meet the needs of different tourists, the park has launched five tourist routes, one is a three-precision panoramic tour for guests with special needs; The second is a pharmaceutical knowledge popularization education tour specially designed for students and consumers; Third, the production process and management tour for company customers and the same industry; Fourth, the industrial park is on tour for leaders from all walks of life to visit and inspect; The fifth is the essence tour of the old industrial park.
Mitsui Industrial Park launches "Free Industrial Tour Experience Activities" every year. Participate in this activity, you can not only walk into the Sanjing production workshop in person, see the whole production process of Sanjing products, but also taste Sanjing calcium gluconate for free and feel the elegance of famous enterprises.
If the landlord wants to go, visit the ticket 15 yuan, and you can taste gluconic acid for free.
2. What is the industry status of Sanjing Pharmaceutical? The product structure of a production enterprise not only represents its production capacity, but also shows its strength and development prospects.
In the early days of the establishment of Sanjing Pharmaceutical, it mainly produced various water injections. After more than 50 years of development, oral solutions can now be produced; Large volume and small volume injection; Tablet computer; Capsule; Freeze-drying agent; Powder spraying; Powder; Particles; Pills; Dropping pills; Aerosol; Spray; Emulsion; Eye drops; Cream; Ointment and other 20 dosage forms, 334 varieties, 454 specifications of products.
Among them, 16 dosage form production line has passed the national GMP certification. In the development process of Sanjing Pharmaceutical, products with market competitiveness are constantly introduced.
In the middle and late 1960s, Ginseng Royal Jelly Oral Liquid, a tonic for human body, which was mainly made of northeast Sambo and bee nutrients, filled the gap in the health care product market at that time, and it is still exported to more than 40 countries and regions such as Japan, South Korea, Mexico, Italy and Canada. In 1990s, the company adjusted its product structure and successively launched a new generation of flagship products, namely Sanjing brand calcium gluconate oral liquid, Sanjing brand zinc gluconate oral liquid, Sanjing brand Shuanghuanglian series products and Sanjing brand Sloping. So far, it has been active in the drug and health care products market in China, and has been recognized by consumers.
The new products recently launched by the company, such as wet itching water and Sanjing Yangrun eye drops, have shown good market development prospects as soon as they are listed. Sanjing Pharmaceutical invested a lot of money in the research and development of new products, concentrated the advantages of various resources, and formed a product development model of "producing one generation, reserving one generation, developing one generation", and the subsequent development momentum was strong.
3. Sanjing Pharmaceutical-related events It is reported that Sanjing Pharmaceutical and Harbin Pharmaceutical Co., Ltd. issued an announcement at the same time on the evening of May 19, confirming that Liu Zhanbin, the current chairman of Sanjing Pharmaceutical, was investigated for suspected bribery and jumped to his death.
Sanjing Pharmaceutical announced that Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. received a notice from Heihe People's Procuratorate on May 18 that Liu Zhanbin, the chairman of the company, was placed on file for investigation on May 16. After breakfast on May 18, Liu Zhanbin said he was unwell.
On the morning of the same day, during the physical examination of Xunke County Hospital, he got rid of the guardianship bailiff in the bathroom on the third floor and jumped out of the window and fell to the ground to die. Since Liu Zhanbin is a director of Harbin Pharmaceutical Co., Ltd., Harbin Pharmaceutical Co., Ltd. also announced the same content mentioned above.
19, it is reported in the industry that Liu Zhanbin was taken away by the procuratorate to assist in the investigation on suspicion of corruption and bribery, and committed suicide by jumping off a building in the hospital on the grounds that he was unwell and asked for treatment. According to public information, Liu Zhanbin is 5 1 year old this year.
In 2009, major personnel changes occurred in the top management of Harbin Pharmaceutical Group. Jiang Linkui, the chairman of Sanjing Pharmaceutical, was transferred, and Wang Jianbo, the former general manager, resigned and left. Liu Zhanbin, former chairman and general manager of Harbin Pharmaceutical Group Chinese Medicine Co., Ltd., became the chairman and general manager of Sanjing Pharmaceutical. However, in 2065438+2002, 65438+ 10, the senior management of Harbin Pharmaceutical Co., Ltd. made another personnel adjustment. Liu Zhanbin ceased to be the general manager of Sanjing Pharmaceutical Co., Ltd. and was replaced by Liu Chunfeng. Liu Zhanbin is still the chairman.
The product structure of Sanjing Pharmaceutical Co., Ltd. is mainly OTC (over-the-counter medicine) and health food, and it is famous in the industry for its "advertising+conference" marketing model. However, in recent years, the OTC market as a whole is not prosperous, and the operating mode of OTC category "channel+advertising" is unsustainable. .
4. How about Shandong Sanjing Pharmaceutical Co., Ltd. Shandong Sanjing Pharmaceutical Co., Ltd. was established in June 1998. It is a comprehensive pharmaceutical enterprise jointly funded by Linyi Mengyang Pharmaceutical Co., Ltd. and Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., which mainly produces Chinese herbal pieces, chemical raw materials, Chinese herbal extracts and pharmaceutical intermediates.
The company is located in Linyi High-tech Industrial Development Zone, covering an area of 80,000 square meters and a total construction area of 36,000 square meters. The company has employees 150, including 50 with college education or above and more than 30 engineers and technicians.
Is a powerful joint-stock enterprise. The company has modern pharmaceutical equipment and advanced quality testing instruments, and has built a production workshop that meets the requirements of G M P and a clean workshop that meets the requirements of 1O purification.
The company obtained the pharmaceutical production license in 2003 and passed the GMP certification of baicalin and Chinese herbal pieces in 2007. It is the only legal enterprise in Shandong province that has obtained the extraction and production of traditional Chinese medicine. The company mainly produces and operates: Chinese herbal medicines, Chinese herbal pieces, Chinese herbal extracts and chemical raw materials.
Engaged in the extraction of traditional Chinese medicine for more than ten years, it produces more than 600 tons of traditional Chinese medicine extract and 5000 tons of processed traditional Chinese medicine, with an annual output value of 654.38+0 billion yuan. The main products are honeysuckle extract (for injection and oral use), forsythia suspensa extract, baicalin (for injection and oral use), Ginkgo biloba extract and other products, among which baicalin, Ginkgo biloba extract and forsythia suspensa extract were included in China Pharmacopoeia in 2005.
The company strictly controls the quality of products, and established a 3000-mu source base of Chinese herbal medicines in Pingyi according to the requirements of GAP, which laid a good material foundation for the long-term development of enterprises. The company plans to invest 654.38+0.7 billion yuan to build oral solid preparation workshop, oral liquid workshop and injection workshop. After being completed and put into production, the company can form the production capacity of tablets, granules, capsules, oral liquids, injections, traditional Chinese medicine extracts, chemical raw materials and traditional Chinese medicine pieces, all of which can form the production scale with an annual output value of 654.38 billion yuan.
Over the years, the company has always implemented the Drug Administration Law, organized production and operation in strict accordance with GMP requirements, set up a quality management department and a quality inspection center, and set up a full-time quality supervisor, forming a complete production and quality assurance system. The company adheres to the management policy of "quality promotes medicine, reputation is supreme", vigorously promotes the enterprise spirit of "being a man, doing things and making medicine for perfection", and relies on the rich advantages of traditional Chinese medicine resources in Yimengshan real estate to inherit and develop the processing technology of traditional Chinese medicine, which provides a strong material guarantee for the broad masses of people to use medicine safely and effectively.
Shandong Sanjing Pharmaceutical Co., Ltd. has received extensive attention from all walks of life. Zhang Jihua, the legal representative, and all the staff are willing to work together for the development and glory of friends from all walks of life and to better protect human health.